Outcomes and safety of concomitant topiramate or metformin for antipsychotics-induced obesity: a randomized-controlled trial

BACKGROUND: Although there are some existing data describing the usage of topiramate in patients with antipsychotic-induced obesity, study on its comparison with metformin is limited. This study aimed to explore the effectiveness and safety of concomitant topiramate on antipsychotic-induced obesity...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Congjie, Shi, Wenjie, Xu, Jianyang, Huang, Chengbing, Zhu, Jiannan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727176/
https://www.ncbi.nlm.nih.gov/pubmed/33302986
http://dx.doi.org/10.1186/s12991-020-00319-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7727176/
https://www.ncbi.nlm.nih.gov/pubmed/33302986
http://dx.doi.org/10.1186/s12991-020-00319-x

Ejemplares similares